SCHEMBL20111858

SCHEMBL20111858

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2ccc(C(F)(F)F)cc2C(F)(F)F)cc(-n2c3ccc(C)cc3c3cc(C)ccc32)c1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
NCOA1 Q15788 1/20 0.35
HIF1A Q16665 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
CYP2C9 P11712 1/20 0.35
SCN9A Q15858 1/20 0.35
AR P10275 4/20 0.34
PTGDR2 Q9Y5Y4 4/20 0.34
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111863 0.95 KIF11 (0.37) KIF11SMN1; SMN2LMNAPOLBHTT
SCHEMBL26777037 0.93 KIF11 (0.35) KIF11SMN1; SMN2LMNAPOLBHTT
SCHEMBL21258708 0.93 AR (0.43) KIF11POLBALDH1A1GLAGAA
SCHEMBL21258836 0.92 ALOX5AP (0.36) KIF11SMN1; SMN2ALDH1A1CYP2C9SCN9A
SCHEMBL21258869 0.92 AR (0.35) KIF11ALDH1A1GLAGAAHPGD
SCHEMBL20111867 0.91 ALDH1A1 (0.35) KIF11SMN1; SMN2LMNAPOLBHTT
SCHEMBL20111811 0.90 KIF11 (0.35) KIF11ALDH1A1GLAGAAHPGD
SCHEMBL21258752 0.90 AR (0.46) SMN1; SMN2POLBALDH1A1GLAGAA
SCHEMBL21258835 0.90 ALOX5AP (0.39) KIF11SMN1; SMN2LMNAHTTALDH1A1
SCHEMBL21258865 0.89 AR (0.35) POLBALDH1A1GLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10971688-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-04-06 US disclosed
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-15 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
WO-2018077492-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10971688-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OPRM1 KIF11 3426/4885SMN1; SMN2 4503/4885LMNA 4134/4885
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KIF11 3661/4885SMN1; SMN2 4580/4885LMNA 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.